Lilly: Medicare Drug Rebate False Claims Case Should Be Reviewed By High Court
CHICAGO — Eli Lilly & Co. urges the U.S. Supreme Court to review a Seventh Circuit U.S. Court of Appeals decision that affirmed a final judgment of $193 million for a...To view the full article, register now.
Already a subscriber? Click here to view full article